To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This chapter provides information on viral zoonotic infections in humans, transmitted from animals, caused by rabiesvirus, influenzaviruses, HEV, poxviruses, hantavirus, Lassa fever virus, ebola, SARS-CoV, MERS-CoV, SARS-CoV-2, nipahvirus, zikavirus. It details which animal hosts are associated with which viruses, modes of spread and strategies for control.
This chapter details the epidemiology, route of spread, prevalence and incubation periods relating to the organisms which cause atypical pneumonia (M.pneumoniae, C.psittaci, C.burnetii, L.pneumophila). It gives information on symptoms, laboratory diagnosis, treatment, and outbreaks.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to VZV. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to RSV. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter provides details of the different kinds of vaccines available (live, attenuated, killed, inactivated, recombinant, subunit, mRNA, DNA and vector) for virus infections (e.g. SARS-CoV-2, HAV, HBV, influenzaviruses, JEE, measlesvirus, mumpsvirus, rubellavirus, HPV, rabies, polio, rotavirus, smallpox, mpox, yellow fever virus) in humans. It details the routes of administration and usage (e.g. pre-exposure or post-exposure, childhood, occupational health, travel and for at-risk groups).
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to chlamydia (C.trachomatis, C.pneumoniae, C. psittaci, C. abortus, LGV). It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to HTLV. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter provides details of the molecular techniques in use to detect viral RNA and DNA, including PCR, NAAT, nested PCR, multiplex PCR, real time PCR, quantitative PCR, LAMP, TMA, microarrays, sequencing and point-of-care tests and their utility.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to human papillomaviruses and polyomaviruses. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, symptoms and prevalence, relating to viral infections acquired while abroad (HBV, HAV, HEV, HIV, noroviruses, dengue fever, arboviruses, haemorrhagic fever viruses, rabies).
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to measles virus. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to human parvovirus B19. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread and prevalence of viruses causing ’the common cold’ (coronaviruses, parainfluenzaviruses, rhinoviruses). It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to poxviruses (smallpox, monkeypox, cowpox, molluscum contagiosum). It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to mumps virus. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter provides details of the viruses associated with maculopapular, vesicular and haemorrhagic skin rashes (parvovirus, rubellavirus, measlesvirus, enteroviruses, adenoviruses, HHV6, HHV7 , HSV, VZV, poxviruses , monkeypox and molluscum contagiosum). It gives details of symptoms, diagnosis and treatment.
This chapter details the epidemiology, route of spread, symptoms, diagnosis, treatment, prophylaxis and infection control relating to viruses causing hepatitis (HAV, HBV, HCV, HDV, HEV, CMV, EBV and arboviruses).